眼前房出血由于玻璃体内注射地塞米松植入物巩膜造口术而无玻璃体积血。
Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage.
机构信息
Department of Medical Science, Neuroscience and Sense Organs, Eye Clinic, University of Bari, 70124, Bari, Italy.
Eye Clinic Section, Department of Surgical Sciences, University of Turin, 10122, Turin, Italy.
出版信息
Eur J Ophthalmol. 2024 Jan;34(1):NP96-NP99. doi: 10.1177/11206721231178058. Epub 2023 May 30.
BACKGROUND
Anterior Chamber bleeding without vitreous hemorrhage had been described after the removal of 23G vitrectomy cannulas. We report the case of an anterior chamber bleeding after an intravitreal Dexamethasone implant.
CASE REPORT
One patient with macular edema due to central retinal vein occlusion in a vitrectomized eye underwent an intravitreal Dexamethasone implant. After the injection the patient suffered from anterior chamber bleeding without signs of vitreous hemorrhage. The complication resolved with a conservative treatment.
CONCLUSION
Anterior Chamber bleeding is a possible complication of dexamethasone implant, that can be treated in a conservative way.
背景
在移除 23G 玻璃体切割套管后，曾有报道称出现无玻璃体积血的前房出血。我们报告了一例玻璃体内注射地塞米松植入物后发生前房出血的病例。
病例报告
一名患有因中央视网膜静脉阻塞导致的黄斑水肿的患者，已行玻璃体切除术，行玻璃体内注射地塞米松植入物。注射后，患者发生前房出血，无玻璃体积血迹象。该并发症经保守治疗后得到缓解。
结论
前房出血是地塞米松植入物的一种可能的并发症，可以通过保守治疗来治疗。
Zotero 插件